0000939767-20-000101.txt : 20200529 0000939767-20-000101.hdr.sgml : 20200529 20200529213644 ACCESSION NUMBER: 0000939767-20-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200529 FILED AS OF DATE: 20200529 DATE AS OF CHANGE: 20200529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRISSEY MICHAEL CENTRAL INDEX KEY: 0001202096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 20930759 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL M DATE OF NAME CHANGE: 20030512 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL R DATE OF NAME CHANGE: 20021029 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_159080258594506.xml FORM 4 X0306 4 2020-05-29 0 0000939767 EXELIXIS, INC. EXEL 0001202096 MORRISSEY MICHAEL C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 1 0 0 President and CEO Common Stock 2020-05-19 5 G 0 E 35935 0 D 85985 D Common Stock 2020-05-19 5 G 0 E 35935 0 A 889574 I By Trust Common Stock 2020-05-29 4 M 0 100000 6.21 A 185985 D Common Stock 2020-05-29 4 F 0 64550 24.71 D 121435 D Common Stock 17728 I By 401(k) Option (right to buy) 6.21 2020-05-29 4 M 0 100000 0 D 2016-09-16 2022-09-15 Common Stock 100000.0 300000 D On May 19, 2020, the Reporting Person gifted 35,935 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Includes 85,985 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,450 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,550 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 29, 2020 of $24.71. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 28, 2020. The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2020-05-29